Skip to Content

AB Biotics - Stock Quote ABB

Rating as of

Morningstar's AB Biotics Stock Analysis

Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

AB Biotics's Company Profile

Business Description

AB Biotics is a biotechnology company engaged in the research and development of probiotics and specialty dietary supplements. It manufactures drugs for cardiometabolic, oral care pediatrics, gastrointestinal, gynecology and urology, dermatology and immunology areas. The company also offers a wide range of genomic services including genetic tests in the fertility and pain treatment fields. Its product offerings include AB-Immuno, AB-sakei 65, AB-Kolicare, AB- Cyscare, AB- Dentalac Pro, AB- Dentalac Junior, among others.

Avinguda. De la Torre Blanca, 57 - Desp. 3B06
Barcelona, 08172, Spain
T +34 935929003
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2019
Fiscal Year End Dec 31, 2019
Stock Type
Employees 34